Veliparib potentiated inhibitory effect of cisplatin, carboplatin and cyclophosphamide towards human BRCA1-mutated breast cancer xenografts (MX-1) growing in immunocompromised mice. The gene discussed is BRCA1; the disease is breast carcinoma.